Sunday, October 04, 2015 10:50:40 AM
The 14 years of being out there with no negative side effects is a very good thing. Weight loss would generally be considered a positive side effect, unless a person was emaciated, then Sucanon might not be a good choice for that individual. But then most type 2 diabetics are overweight and not underweight.
As for the future of Roth and Sucanon, this will be determined by expansion into new (countries) markets and resulting sales. There is a huge potential as type 2 diabetes is growing and becoming a world wide epidemic. There is a huge market that is only growing. I believe that once a major distribution agreement is signed and marketed successfully through doctors, hospitals and clinics, Sucanon sales and stock price will rise in lock-step. If /when this occurs it will be "off to the races" and many will be kicking themselves for not buying in at 1/2 cent.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM